Get up to $150k to support drug discovery from U-M Therapeutic Innovation Fund

June 14, 2021  //  FOUND IN: Updates & Resources

The U-M Therapeutic Innovation Fund, offered by the Michigan Center for Therapeutic Innovation (MCTI) and Fast Forward Medical Innovation, is a five-year, $2.5 million fund created in 2016 to accelerate the discovery and translation of therapeutic candidates at U-M.

The fund supports the discovery and optimization of small molecule lead compounds for projects with a specific, novel and testable drug discovery hypothesis.

Selected projects receive funding and resources to support medicinal chemistry efforts through MCTI and funding for drug design, assay development, cell biology, structural biology and pharmacology (up to $150,000 in value for each award for a period of 18 months with the funds being disbursed in two stages). The fund is jointly administered by MCTI and FFMI.

The submission deadline is Friday, Sept. 10 at 5 p.m.